Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04365920 · ClinicalTrials.gov registry record · Phase 3

Recovery Management Checkups for Opioid Use Disorder Experiment

A Phase 3 study of Opioid Use Disorder, sponsored by Chestnut Health Systems.

Active
Registry status
Phase 3
Development phase
455
Enrollment target
1
Study location

NCT04365920 is a Phase 3 study of Opioid Use Disorder that is active but no longer recruiting, run by Chestnut Health Systems. The registered enrollment target is 455 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04365920, a Phase 3 study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Chestnut Health Systems.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
455 participants
Enrollment target
1
Study location

Study Summary

The experiment will be conducted in collaboration with 6 jails representing discrete geographic counties in Illinois and the opioid treatment providers (OTP) that serve them. It will compare a re-entry as usual control group with two experimental groups in terms of their impact on the OUD service cascade, as well as public health and public safety outcomes. Study recruitment sites are six jails that provide treatment with medication for opioid use disorder (MOUD) to inmates with OUD prior to their release. At the time of their release to the community, 750 men and women will be randomly assigned to 1 of 3 groups: a) a re-entry as usual control, b) RMC with monthly checkups for 3 months post-release followed by quarterly checkups up to 2 years, or c) an adaptive version of RMC (RMC-A) that includes a modified checkup schedule based on each individual's pattern of treatment need. All participants will complete research interviews at release and quarterly thereafter up to 2 years post-enrollment.

Conditions Studied

Opioid Use Disorder

Interventions

  • COMBINATION_PRODUCT Recovery Management Checkups (RMC)
  • COMBINATION_PRODUCT RMC-Adaptive

Study Locations (1)

Illinois

  • Chestnut Health Systems-Lighthouse Institute - Chicago

Trial Details

FieldValue
Enrollment Target 455 participants
Start Date 2021-08-29
Est. Completion 2025-06-30
Phase Phase 3

Sponsor

Chestnut Health Systems

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04365920

The ClinicalTrials.gov registry entry for NCT04365920 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Chestnut Health Systems, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Recovery Management Checkups (RMC) is the first listed.

NCT04365920 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04365920 about?

NCT04365920 is a clinical study titled "Recovery Management Checkups for Opioid Use Disorder Experiment". The experiment will be conducted in collaboration with 6 jails representing discrete geographic counties in Illinois and the opioid treatment providers (OTP) that serve them. It will compare a re-entry as usual control group with two experimental groups in terms of their impact on the OUD service ca...

What is the current status of trial NCT04365920?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 455 participants. The study started on 2021-08-29. Estimated completion is 2025-06-30.

What conditions does trial NCT04365920 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04365920?

The interventions under investigation include: Recovery Management Checkups (RMC) (COMBINATION_PRODUCT), RMC-Adaptive (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT04365920?

This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04365920 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.